Grants and Contributions:
Title:
Development of a molecular test for the early detection and screening of lung cancer
Agreement Number:
980330
Agreement Value:
$169,550.00
Agreement Date:
Oct 4, 2021 - Oct 31, 2022
Description:
Development of a non-invasive, highly sensitive and accurate molecular test for the early detection and screening of lung cancer
Organization:
National Research Council Canada
Expected Results:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Location:
Quebec, Quebec, CA G1P 4P5
Reference Number:
172-2021-2022-Q3-980330
Agreement Type:
Contribution
Report Type:
Grants and Contributions
Recipient Business Number:
796635662
Recipient Type:
For-profit organization
Additional Information:
This agreement has been amended 1 time(s). The end date of this agreements has been modified by 50 days.
Amendment Date
Jul 18, 2022
Recipient's Operating Name:
Biomark Diagnostic Solutions inc.
Recipient's Legal Name:
Solutions de Diagnostic Biomark inc.
Federal Riding Name:
Québec
Federal Riding Number:
24059
Program:
Industrial Research Assistance Program – Contributions to Firms
Program Purpose:
The purpose of IRAP Contributions to Firms is to support research, development, adoption and/or adaptation of innovative or technology-driven new or improved products, services or processes in Canada up to their commercialization
Coverage:
IRAP Contributions to Firms projects stimulate wealth creation for Canada through technological innovation.
NAICS Code:
334512
Amendments: